Symetryx Corp - Dec 31, 2022 Form 5 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
no longer 10% Owner
Signature
Barry Shiff
Stock symbol
NBSE
Transactions as of
Dec 31, 2022
Transactions value $
$0
Form type
5
Date filed
9/20/2023, 08:42 PM
Next filing
Sep 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBSE Common Stock, par value $0.0001 Other $0 0 0% $0.00* 192K Sep 18, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Symetryx Corp is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 (1) Symetryx Corporation reported the sales of all its Common Stock of Issuer on Form 4 filed 9/18/2023. Barry and Aleta Shiff are beneficial owners of shares listed.

Remarks:

Barry Shiff, President of Symetryx Corporation, is the authorized signatory for Symetryyx Corporation, himself, and Aleta Shiff.